Gheyath K Nasrallah

InstitutionQatar University
AddressDoha
Qatar
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 20 Covid-19 publications, with a maximum of 3 publications in July 2021
    All Publications
    Bar chart showing 64 publications over 11 distinct years, with a maximum of 13 publications in 2018 and 2021
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Abu-Raddad LJ, Chemaitelly H, Yassine HM, Benslimane FM, Al Khatib HA, Tang P, Malek JA, Coyle P, Ayoub HH, Al Kanaani Z, Al Kuwari E, Jeremijenko A, Kaleeckal AH, Latif AN, Shaik RM, Abdul Rahim HF, Nasrallah GK, Al Kuwari MG, Al Romaihi HE, Al-Thani MH, Al Khal A, Butt AA, Bertollini R. Pfizer-BioNTech mRNA BNT162b2 Covid-19 vaccine protection against variants of concern after one versus two doses. J Travel Med. 2021 10 11; 28(7). PMID: 34050372.
      Citations: 6     Fields:    Translation:Humans
    2. Shurrab FM, Al-Sadeq DW, Amanullah F, Younes SN, Al-Jighefee H, Younes N, Dargham SR, Yassine HM, Abu Raddad LJ, Nasrallah GK. Effect of multiple freeze-thaw cycles on the detection of anti-SARS-CoV-2 IgG antibodies. J Med Microbiol. 2021 Aug; 70(8). PMID: 34356000.
      Citations:    Fields:    Translation:Humans
    3. Ismail A, Shurrab FM, Al-Jighefee HT, Al-Sadeq DW, Qotba H, Al-Shaar IA, Yassine HM, Abu-Raddad LJ, Nasrallah GK. Can commercial automated immunoassays be utilized to predict neutralizing antibodies after SARS-CoV-2 infection? A comparative study between three different assays. Front Biosci (Landmark Ed). 2021 07 30; 26(7):198-206. PMID: 34340267.
      Citations: 1     Fields:    Translation:Humans
    4. Chemaitelly H, Yassine HM, Benslimane FM, Al Khatib HA, Tang P, Hasan MR, Malek JA, Coyle P, Ayoub HH, Al Kanaani Z, Al Kuwari E, Jeremijenko A, Kaleeckal AH, Latif AN, Shaik RM, Abdul Rahim HF, Nasrallah GK, Al Kuwari MG, Al Romaihi HE, Al-Thani MH, Al Khal A, Butt AA, Bertollini R, Abu-Raddad LJ. mRNA-1273 COVID-19 vaccine effectiveness against the B.1.1.7 and B.1.351 variants and severe COVID-19 disease in Qatar. Nat Med. 2021 09; 27(9):1614-1621. PMID: 34244681.
      Citations: 34     Fields:    Translation:Humans
    5. Syed MA, Al Nuaimi AS, A/Qotba HA, Nasrallah GK, Althani AA, Yassine HM, Zainel AA, Khudadad H, Marji T, Veettil ST, Al-Jighefee HT, Younes S, Shurrab F, Al-Sadeq DW, AlFehaidi AAS, Yfakhroo AI, AlMesaifri MA, Al Mujalli H, Al Abdulla SA, Al Kuwari MG, Azad FM, Al Malki BAM, Abdulmalik MA. Epidemiology of SARS-CoV2 in Qatar's primary care population aged 10 years and above. BMC Infect Dis. 2021 Jul 05; 21(1):645. PMID: 34225657.
      Citations: 2     Fields:    Translation:Humans
    6. Nasrallah GK, Dargham SR, Shurrab F, Al-Sadeq DW, Al-Jighefee H, Chemaitelly H, Al Kanaani Z, Al Khal A, Al Kuwari E, Coyle P, Jeremijenko A, Kaleeckal AH, Latif AN, Shaik RM, Rahim HFA, Yassine HM, Al Kuwari MG, Qotba H, Al Romaihi HE, Tang P, Bertollini R, Al-Thani MH, Althani AA, Abu-Raddad LJ. Analytic comparison between three high-throughput commercial SARS-CoV-2 antibody assays reveals minor discrepancies in a high-incidence population. Sci Rep. 2021 06 04; 11(1):11837. PMID: 34088944.
      Citations: 4     Fields:    Translation:Humans
    7. A/Qotba HA, Hamed E, Alnuaimi AS, Saad AA, Nasrallah GK, Alnaama AA, Syed MA. SARS-CoV-2 infection among primary healthcare workers: a cross-sectional study. Germs. 2021 Jun; 11(2):324-328. PMID: 34422704.
      Citations:    
    8. Coyle PV, Chemaitelly H, Ben Hadj Kacem MA, Abdulla Al Molawi NH, El Kahlout RA, Gilliani I, Younes N, Al Anssari GAAA, Al Kanaani Z, Al Khal A, Al Kuwari E, Butt AA, Jeremijenko A, Kaleeckal AH, Latif AN, Shaik RM, Abdul Rahim HF, Nasrallah GK, Yassine HM, Al Kuwari MG, Al Romaihi HE, Al-Thani MH, Bertollini R, Abu-Raddad LJ. SARS-CoV-2 seroprevalence in the urban population of Qatar: An analysis of antibody testing on a sample of 112,941 individuals. iScience. 2021 Jun 25; 24(6):102646. PMID: 34056566.
      Citations: 10     
    9. Citations: 5     
    10. Abu-Raddad LJ, Chemaitelly H, Coyle P, Malek JA, Ahmed AA, Mohamoud YA, Younuskunju S, Ayoub HH, Al Kanaani Z, Al Kuwari E, Butt AA, Jeremijenko A, Kaleeckal AH, Latif AN, Shaik RM, Abdul Rahim HF, Nasrallah GK, Yassine HM, Al Kuwari MG, Al Romaihi HE, Al-Thani MH, Al Khal A, Bertollini R. SARS-CoV-2 antibody-positivity protects against reinfection for at least seven months with 95% efficacy. EClinicalMedicine. 2021 May; 35:100861. PMID: 33937733.
      Citations: 22     
    11. Ayoub HH, Chemaitelly H, Makhoul M, Al Kanaani Z, Al Kuwari E, Butt AA, Coyle P, Jeremijenko A, Kaleeckal AH, Latif AN, Shaik RM, Abdul Rahim HF, Nasrallah GK, Yassine HM, Al Kuwari MG, Al Romaihi HE, Al-Thani MH, Bertollini R, Al Khal A, Abu-Raddad LJ. Epidemiological impact of prioritising SARS-CoV-2 vaccination by antibody status: mathematical modelling analyses. BMJ Innov. 2021 Apr; 7(2):327-336. PMID: 34192020.
      Citations: 6     
    12. Al-Jighefee HT, Yassine HM, Nasrallah GK. Evaluation of Antibody Response in Symptomatic and Asymptomatic COVID-19 Patients and Diagnostic Assessment of New IgM/IgG ELISA Kits. Pathogens. 2021 Feb 03; 10(2). PMID: 33546341.
      Citations: 7     
    13. Younes S, Al-Jighefee H, Shurrab F, Al-Sadeq DW, Younes N, Dargham SR, Al-Dewik N, Qotba H, Syed M, Alnuaimi A, Yassine HM, Tang P, Abu-Raddad LJ, Nasrallah GK. Diagnostic Efficiency of Three Fully Automated Serology Assays and Their Correlation with a Novel Surrogate Virus Neutralization Test in Symptomatic and Asymptomatic SARS-COV-2 Individuals. Microorganisms. 2021 Jan 25; 9(2). PMID: 33504067.
      Citations: 5     
    14. Marei RM, Emara MM, Elsaied OM, Nasrallah GK, Chivese T, Al-Romaihi HE, Althani MH, Al Thani AA, Farag EA, Farag EA, Yassine HM. Demographic and Clinical Characteristics of Early Travel-Associated COVID-19 Cases. Front Public Health. 2020; 8:573925. PMID: 33425831.
      Citations: 2     Translation:HumansPHPublic Health
    15. Younes S, Younes N, Shurrab F, Nasrallah GK. Severe acute respiratory syndrome coronavirus-2 natural animal reservoirs and experimental models: systematic review. Rev Med Virol. 2021 07; 31(4):e2196. PMID: 33206434.
      Citations: 11     Fields:    Translation:AnimalsCells
    16. Yassine HM, Al-Jighefee H, Al-Sadeq DW, Dargham SR, Younes SN, Shurrab F, Marei RM, Hssain AA, Taleb S, Alhussain H, Al-Nesf MA, Al-Khal A, Qotba H, Althani AA, Tang P, Abu-Raddad LJ, Nasrallah GK. Performance evaluation of five ELISA kits for detecting anti-SARS-COV-2 IgG antibodies. Int J Infect Dis. 2021 Jan; 102:181-187. PMID: 33127504.
      Citations: 10     Fields:    Translation:Humans
    17. Siddiqui M, Manansala JS, Abdulrahman HA, Nasrallah GK, Smatti MK, Younes N, Althani AA, Yassine HM. Immune Modulatory Effects of Vitamin D on Viral Infections. Nutrients. 2020 Sep 21; 12(9). PMID: 32967126.
      Citations: 15     Fields:    Translation:HumansCellsPHPublic Health
    18. Paliogiannis P, Mangoni AA, Dettori P, Nasrallah GK, Pintus G, Zinellu A. D-Dimer Concentrations and COVID-19 Severity: A Systematic Review and Meta-Analysis. Front Public Health. 2020; 8:432. PMID: 32903841.
      Citations: 24     Translation:HumansPHPublic Health
    19. Al-Sadeq DW, Nasrallah GK. The incidence of the novel coronavirus SARS-CoV-2 among asymptomatic patients: A systematic review. Int J Infect Dis. 2020 Sep; 98:372-380. PMID: 32623083.
      Citations: 31     Fields:    Translation:HumansCellsPHPublic Health
    20. Younes N, Al-Sadeq DW, Al-Jighefee H, Younes S, Al-Jamal O, Daas HI, Yassine HM, Nasrallah GK. Challenges in Laboratory Diagnosis of the Novel Coronavirus SARS-CoV-2. Viruses. 2020 05 26; 12(6). PMID: 32466458.
      Citations: 83     Fields:    Translation:HumansCellsPHPublic Health
    21. Al Kahlout RA, Nasrallah GK, Farag EA, Farag EA, Wang L, Lattwein E, Müller MA, El Zowalaty ME, Al Romaihi HE, Graham BS, Al Thani AA, Yassine HM. Comparative Serological Study for the Prevalence of Anti-MERS Coronavirus Antibodies in High- and Low-Risk Groups in Qatar. J Immunol Res. 2019; 2019:1386740. PMID: 30906787.
      Citations: 27     Fields:    Translation:HumansCells
    Nasrallah's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (183)
    Explore
    _
    Co-Authors (129)
    Explore
    _
    Similar People (60)
    Explore
    _